• Leave Your Message
    Products Categories
    Featured Products

    DABIGATRAN ETEXILATE CAS No. 211915-06-9 Pharmaceutical Intermediates

    Product name

    DABIGATRAN ETEXILATE

    Other name

    N-[2-[4-[N-(HEXYLOXYCARBONYL)AMIDINO]PHENYLAMINOMETHYL]-1-METHYL-1H-BENZIMIDAZOL-5-YLCARBONYL]-N-(2-PYRIDYL)-BETA-ALANINE ETHYL ESTER

    CAS No. 

    211915-06-9

    EINECS  

    606-722-8

    Formula 

    C34H41N7O5

    Molecular Weight

    627.73

    Appearance

    white to off-white crystalline powder

    Purity

    ≥98%

    Type

    Pharmaceutical Intermediates

    -‌ Innovative Anticoagulant‌: Offers superior efficacy and safety compared to traditional anticoagulants.

    -‌ Excellent Bioavailability‌: Ensures rapid and consistent absorption for maximum therapeutic effect.

    -‌ Low Bleeding Risk‌: Demonstrates a reduced risk of bleeding complications.

    -‌ Comprehensive Lab Support‌: Compatible with advanced laboratory instruments and consumables for precise analysis.

    -‌ Global Reach & Expertise‌: Backed by a trusted foreign trade company with extensive experience in pharmaceutical exports.

      Product details

      DABIGATRAN ETEXILATE 211915-06-9 (1)
      02

      introduction

      In the dynamic field of cardiovascular medicine, Dabigatran Etexilate stands as a testament to innovation and progress. As a leading foreign trade company specializing in high-quality pharmaceutical products, we are proud to offer this revolutionary anticoagulant that is transforming the way we manage and prevent blood clots.

      Dabigatran Etexilate is a prodrug that, upon oral administration, is rapidly converted into its active form, dabigatran. This unique molecule exhibits exceptional physicochemical properties that contribute to its superior performance as an anticoagulant. With a high affinity for thrombin, dabigatran directly inhibits the enzyme's activity, thereby preventing the formation of blood clots.
      CAS No
      02

      Physical and chemical properties

      1. Excellent bioavailability: The prodrug design ensures that it is efficiently absorbed in the gastrointestinal tract, leading to rapid and consistent plasma concentrations. This ensures that patients receive the full therapeutic benefit of the drug with minimal variability in response.

      2. Pharmacokinetic profile: With a predictable half-life that allows for once- or twice-daily dosing, enhancing patient compliance and convenience. Its low protein binding and minimal metabolic interactions reduce the risk of drug-drug interactions, making it a safe choice for patients with comorbid conditions.

      advantage

      ‌1. Reduced Bleeding Risk‌: One of the most significant concerns with traditional anticoagulants is the risk of bleeding complications. Dabigatran Etexilate has been clinically proven to have a lower incidence of bleeding compared to other anticoagulants, providing patients with a safer treatment option.

      ‌2. Ease of Use‌: The convenient dosing schedule and lack of dietary restrictions associated with Dabigatran Etexilate make it an attractive choice for both patients and healthcare providers. Unlike some anticoagulants that require frequent monitoring and adjustments, Dabigatran Etexilate offers a more straightforward treatment regimen.

      ‌3. Comprehensive Lab Support‌: Recognizing the importance of precise monitoring and analysis, Dabigatran Etexilate is fully compatible with a wide range of laboratory instruments and consumables. From coagulation analyzers to chromatographic systems, our product ensures seamless integration into your laboratory's existing workflows, facilitating accurate and reliable testing.

      ‌4. Global Expertise and Reach‌: As a foreign trade company with a strong presence in the international pharmaceutical market, we bring a wealth of experience and resources to our clients. Our extensive network of suppliers, distributors, and regulatory experts ensures that Dabigatran Etexilate meets the highest standards of quality and compliance, regardless of your location.

      why choose us?

      When you partner with us for Dabigatran Etexilate, you're not just getting a product – you're gaining access to a comprehensive suite of services and support. Our dedicated team of professionals is committed to providing you with the highest level of customer service, from product selection and ordering to technical support and regulatory assistance.

      We understand the unique challenges and opportunities that come with operating in a global market. That's why we offer flexible pricing options, reliable logistics solutions, and customized packaging to meet your specific needs. Whether you're a small research institution or a large pharmaceutical company, we have the expertise and resources to support your success.

      conclusion

      In conclusion, Dabigatran Etexilate represents a significant advancement in anticoagulant therapy, offering superior efficacy, safety, and convenience.

      Its innovative mechanism of action, favorable pharmacokinetic profile, and compatibility with advanced laboratory instruments make it an indispensable tool for managing and preventing blood clots.

      Partner with us today to experience the benefits of this revolutionary anticoagulant and improve the cardiovascular health of your patients.